Candidate HIV-1 Tat vaccine development:: from basic science to clinical trials

被引：59
作者：
Ensoli, Barbara
Fiorelli, Valeria
Ensoli, Fabrizio
Cafaro, Aurelio
Titti, Fausto
Butto, Stefano
Monini, Paolo
Magnani, Mauro
Caputo, Antonella
Garaci, Enrico
机构：
[1] Ist Super Sanita, Natl AIDS Ctr, I-00161 Rome, Italy
[2] Univ Urbino, I-61029 Urbino, Italy
[3] San Gallicano Hosp, Rome, Italy
[4] Univ Padua, Padua, Italy
来源：
AIDS | 2006年 / 20卷 / 18期
关键词：
AIDS vaccine; clinical trials; HIV community; Tat; translational research;
D O I：
10.1097/QAD.0b013e3280112cd1
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：2245 / 2261
页数：17
相关论文
共 133 条
[1]   The HIV-1 regulatory proteins Tat and Rev are frequently targeted by cytotoxic T lymphocytes derived from HIV-1-infected individuals [J].
Addo, MM ;
Altfeld, M ;
Rosenberg, ES ;
Eldridge, RL ;
Philips, MN ;
Habeeb, K ;
Khatri, A ;
Brander, C ;
Robbins, GK ;
Mazzara, GP ;
Goulder, PJR ;
Walker, BD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (04) :1781-1786
[2]   Tat-vaccinated macaques do not control simian immunodeficiency virus SIVmac239 replication [J].
Allen, TM ;
Mortara, L ;
Mothé, BR ;
Liebl, M ;
Jing, PC ;
Calore, B ;
Piekarczyk, M ;
Ruddersdorf, R ;
O'Connor, DH ;
Wang, X ;
Wang, CX ;
Allison, DB ;
Altman, JD ;
Sette, A ;
Desrosiers, RC ;
Sutter, G ;
Watkins, DI .
JOURNAL OF VIROLOGY, 2002, 76 (08) :4108-4112
[3]   Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia [J].
Allen, TM ;
O'Connor, DH ;
Jing, PC ;
Dzuris, JL ;
Mothé, BR ;
Vogel, TU ;
Dunphy, E ;
Liebl, ME ;
Emerson, C ;
Wilson, N ;
Kunstman, KJ ;
Wang, XC ;
Allison, DB ;
Hughes, AL ;
Desrosiers, RC ;
Altman, JD ;
Wolinsky, SM ;
Sette, A ;
Watkins, DI .
NATURE, 2000, 407 (6802) :386-390
[4]   Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine [J].
Amara, RR ;
Villinger, F ;
Altman, JD ;
Lydy, SL ;
O'Neil, SP ;
Staprans, SI ;
Montefiori, DC ;
Xu, Y ;
Herndon, JG ;
Wyatt, LS ;
Candido, MA ;
Kozyr, NL ;
Earl, PL ;
Smith, JM ;
Ma, HL ;
Grimm, BD ;
Hulsey, ML ;
McClure, HM ;
McNicholl, JM ;
Moss, B ;
Robinson, HL .
VACCINE, 2002, 20 (15) :1949-1955
[5]   Critical role for Env as well as Gag-Pol in control of a simian-human immunodeficiency virus 89.6P challenge by a DNA prime/recombinant modified vaccinia virus Ankara vaccine [J].
Amara, RR ;
Smith, JM ;
Staprans, SI ;
Montefiori, DC ;
Villinger, F ;
Altman, JD ;
O'Neil, SP ;
Kozyr, NL ;
Xu, Y ;
Wyatt, LS ;
Earl, PL ;
Herndon, JG ;
McNicholl, JM ;
McClure, HM ;
Moss, B ;
Robinson, HL .
JOURNAL OF VIROLOGY, 2002, 76 (12) :6138-6146
[6]   TRANS-ACTIVATOR GENE OF HUMAN T-LYMPHOTROPIC VIRUS TYPE-III (HTLV-III) [J].
ARYA, SK ;
GUO, C ;
JOSEPHS, SF ;
WONGSTAAL, F .
SCIENCE, 1985, 229 (4708) :69-73
[7]   Induction of HIV-1 specific mucosal immune responses by DNA vaccination [J].
Asakura, Y ;
Hinkula, J ;
Leandersson, AC ;
Fukushima, J ;
Okuda, K ;
Wahren, B .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1997, 46 (04) :326-330
[8]  
Asakura Y, 1996, AM J HEMATOL, V53, P116, DOI 10.1002/(SICI)1096-8652(199610)53:2&lt
[9]  
116::AID-AJH9&gt
[10]  
3.0.CO
12345678910